Delivra Health Brands Inc. (DHB.V)
CAD 0.02
(0.0%)
CAD 0.02
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 12.37 Million CAD | 26.42% |
| 2022 | 9.79 Million CAD | 20.3% |
| 2021 | 8.13 Million CAD | 2.3% |
| 2020 | 7.95 Million CAD | 2.24% |
| 2019 | 7.78 Million CAD | 30.09% |
| 2018 | 5.98 Million CAD | 724.0% |
| 2017 | 725.97 Thousand CAD | 855.86% |
| 2016 | 75.95 Thousand CAD | 0.0% |
| 2015 | - CAD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 Q3 | 3.07 Million CAD | 49.8% |
| 2023 Q4 | 3.58 Million CAD | 16.77% |
| 2023 Q2 | 2.04 Million CAD | -44.16% |
| 2023 Q1 | 3.67 Million CAD | 10.67% |
| 2022 Q3 | 2.35 Million CAD | -1.63% |
| 2022 Q4 | 3.31 Million CAD | 40.97% |
| 2022 Q2 | 2.39 Million CAD | 38.35% |
| 2022 FY | 9.79 Million CAD | 20.3% |
| 2022 Q1 | 1.72 Million CAD | -10.04% |
| 2021 Q1 | 2.13 Million CAD | 0.0% |
| 2021 FY | 8.13 Million CAD | 2.3% |
| 2021 Q4 | 1.92 Million CAD | -17.83% |
| 2021 Q3 | 2.33 Million CAD | 33.96% |
| 2021 Q2 | 1.74 Million CAD | -18.03% |
| 2020 FY | 7.95 Million CAD | 2.24% |
| 2019 FY | 7.78 Million CAD | 30.09% |
| 2018 FY | 5.98 Million CAD | 724.0% |
| 2017 FY | 725.97 Thousand CAD | 855.86% |
| 2016 FY | 75.95 Thousand CAD | 0.0% |
| 2015 FY | - CAD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | 254.89 Thousand CAD | -4756.098% |
| CanadaBis Capital Inc. | 22.22 Million CAD | 44.3% |
| Decibel Cannabis Company Inc. | 115.95 Million CAD | 89.325% |
| Entourage Health Corp. | 40.71 Million CAD | 69.597% |
| Lifeist Wellness Inc. | 21.65 Million CAD | 42.853% |
| Cannara Biotech Inc. | 57.26 Million CAD | 78.383% |
| Medicure Inc. | 21.69 Million CAD | 42.943% |
| PharmaCielo Ltd. | 1.54 Million CAD | -702.854% |
| Rubicon Organics Inc. | 40.11 Million CAD | 69.145% |
| BioSyent Inc. | 31.59 Million CAD | 60.817% |
| Voyageur Pharmaceuticals Ltd. | - CAD | -Infinity% |